¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"vitreous degeneration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • vitreous membrane
    À¯¸®Ã¼¸·
  • vitreous opacity
    À¯¸®Ã¼È¥Å¹
  • vitreous separation
    À¯¸®Ã¼ºÐ¸®
  • vitreous syneresis
    À¯¸®Ã¼¾×È­
  • vitreous tap
    À¯¸®Ã¼ÃµÀÚ
  • angiolithic degeneration
    Ç÷°üµ¹º¯¼º, ¸Æ°ü°á¼®º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
  • ballooning degeneration
    dz¼±º¯¼º
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÇà
  • disciform macular degeneration
    ¿ø¹ÝȲ¹Ýº¯¼º
  • elastotic degeneration
    ź·Â¼¶À¯º¯¼º
  • fatty degeneration
    Áö¹æº¯¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • organized vitreous
    ±âÁúÈ­À¯¸®Ã¼
  • vitreous opacity
    À¯¸®Ã¼È¥Å¹
  • vitreous separation
    À¯¸®Ã¼ºÐ¸®
  • vitreous strand
    À¯¸®Ã¼°¡´Ú
  • vitreous syneresis
    À¯¸®Ã¼¾×È­
  • vitreous tap
    À¯¸®Ã¼ÃµÀÚ
  • vitreous
    À¯¸®Ã¼-, À¯¸®Ã¼
  • actinic degeneration
    ±¤¼±º¯¼º
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
  • angiolithic degeneration
    ¸Æ°ü°á¼®º¯¼º, Ç÷°üµ¹º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
  • ballooning degeneration
    dz¼±º¯¼º
  • cobblestone degeneration
    ÀÚ°¥¸ð¾çº¯¼º, Á¶¾àµ¹º¯¼º
  • cystic degeneration
    ³¶º¯¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º.
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º.
  • hereditary macular degeneration
    À¯Àü¼º Ȳ¹Ýº¯¼º(ë¶îîàõüÜÚèܨàõ).
  • hyaloideoretinal degeneration
    À¯¸®Ã¼¸Á¸·º¯¼º
  • pigmentary degeneration of retina
    ¸Á¸·»ö¼Òº¯¼º(Áõ)(ØÑدßäáÈܨàõ(ñø))
  • pigmentary retinal degeneration
    ¸Á¸·»ö¼Òº¯¼º
  • pigmentary retinal degeneration
    ¸Á¸·»ö¼Òº¯¼º(Áõ).(ØÑدßäáÈܨàõ(ñø))
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõܨ àõ).
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõ ܨàõ)
  • primary degeneration
    ÀÏÂ÷º¯¼º(ìéó­Ü¨àõ)
  • progressive lenticular degeneration
    ÁøÇ༺ ·»ÁîÇÙº¯¼º(Áõ)(òäú¼àõ¡­ú·Ü¨àõ(ñø))
  • pyramidal degeneration
    Ãßüº¯¼º(õÞô÷ܨàõ)
  • red degeneration
    Àû»öº¯¼º(îåßäܨàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • secondary vitreous
    ÀÌÂ÷À¯¸®Ã¼(ì£ó­ë´×îô÷)
  • stroma of vitreous body
    À¯¸®Ã¼¹öÆÀÁú
  • tertiary vitreous
    »ïÂ÷À¯¸®Ã¼(ß²ó­ë¤×ãô÷).
  • vitreous
    ÃÊÀÚü, À¯¸®Ã¼.
  • vitreous
    À¯¸®Ã¼.
  • vitreous abscess
    À¯¸®Ã¼³ó¾ç(ôúí­ô÷ÒÛåË).
  • vitreous abscess
    ÃÊÀÚü³ó¾ç(ôúí­ô÷ÒÛåË)
  • vitreous base
    À¯¸®Ã¼±âÀú
  • vitreous base dissection
    À¯¸®Ã¼±âÀúºÎ¹Ú¸®¼ú
  • vitreous body
    À¯¸®Ã¼(õ¦í­ô÷).
  • vitreous body
    ÃÊÀÚü(õ¦í­ô÷).
  • vitreous body
    À¯¸®Ã¼
  • vitreous borax
    ÃÊÀÚ¾çºØ»ç(¡­åÆÝÚÞã).
  • vitreous borax
    ÃÊÀÚ¾çºØ»ç(¡­åÆÝÚÞã)
  • vitreous bulge
    À¯¸®Ã¼µ¹Ãâ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PHPV persistent hyperplastic primary vitreous
PVD patient very disturbed; peripheral vascular disease; portal vein dilation; posterior vitreous detach...
UGH+ uveitis-glaucoma-hyphema plus vitreous hemorrhage [syndrome]
VF left leg [electrode]; ventricular fibrillation; ventricular fluid; ventricular flutter; visual field...
VISC vitreous infusion suction cutter
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AMD Age related macular degeneration
CBD Cortico-basal degeneration
HLD Hepatolenticular degeneration
Mnd Motor neuron degeneration
NFD Neurofibrillary degeneration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • colloid degeneration
    ÄÝ·ÎÀÌµå º¯¼º
  • corneal degeneration
    °¢¸· º¯¼º
  • cystic degeneration
    ³¶»ó º¯¼º, ³¶Á¾ º¯¼º
  • cystoid degeneration
    À¯³¶»ó º¯¼º
  • degeneration of pulp
    Ä¡¼öÀÇ ÅðÈ­
    ³ëÈ­ µîÀÇ ¿µÇâÀ¸·Î Ä¡¼ö°¡ À§ÃàµÇ°í Ä¡¼ö°­ÀÌ Á¼¾ÆÁö´Â °Í.
  • disk degeneration
    ¿øÆÇ º¯¼º
  • fat degeneration
    Áö¹æ º¯¼º
  • fibrinoid degeneration
    ¼¶À¯¼Ò¾ç º¯¼º, ¼¶À¯¾ç º¯¼º
    µ¿ÀǾî=fibrinoid swelling.
  • hyaline degeneration
    À¯¸®Áú º¯¼º
    ¼¼Æ÷ÁúÀÌ ±ÕÁúÀÌ À¯¸® ¸ð¾çÀΠȣ»ê¼ºÀÇ ¸ð¾çÀ» ³ªÅ¸³»´Â ÅðÇ༺ ¼¼Æ÷ º¯È­.
  • joint degeneration
    °üÀý ÅðÇà
  • liquefactive degeneration
    ¾×È­ º¯¼º
  • malignant degeneration
    ¾Ç¼ºÈ­
  • mosaic corneal degeneration
    ¸ðÀÚÀÌÅ© °¢¸· º¯¼º
  • myocardial degeneration
    ½É±Ù º¯¼º
  • myopic degeneration
    ±Ù½Ã¼º º¯¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
persistent posterior hyperplastic primary vitreous A unilateral congenital anomaly in full-term infants; associated with a congenital retinal fold and a vitreous membranous stalk containing remnants of the hyaloid artery.
(05 Mar 2000)
coloboma of vitreous A congenital indentation of the vitreous body by mesoderm; associated with severe myopia.
(05 Mar 2000)
primary vitreous The vitreous first formed in the embryo between the optic cup and the lens vesicle, and later vascularised by the hyaloid artery and its branches.
(05 Mar 2000)
secondary vitreous Avascular vitreous formed around the primary vitreous.
(05 Mar 2000)
stroma of vitreous The delicate framework of the vitreous body embedded in or enclosing the vitrous humor.
Synonym: stroma vitreum.
(05 Mar 2000)
tertiary vitreous Vitreous fibrils derived from the neuroepithelium of the ciliary body and forming the ciliary zonule.
(05 Mar 2000)
adipose degeneration Abnormal formation of microscopically visible droplets of fat in the cytoplasm of cells, as a result of injury.
Synonym: adipose degeneration, steatosis.
(05 Mar 2000)
adiposogenital degeneration A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms.
Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism.
Origin: L. Fr. G. Dys-, bad, + trophe, nourishment
(05 Mar 2000)
age-related macular degeneration A common macular degeneration beginning with drusen of the macula and pigment disruption and sometimes leading to severe loss of central vision.
(05 Mar 2000)
albuminous degeneration An obsolete terms for cloudy swelling.
(05 Mar 2000)
amyloid degeneration Infiltration of amyloid between cells and fibres of tissues and organs.
Synonym: waxy degeneration.
(05 Mar 2000)
angiolithic degeneration Calcareous degeneration of the walls of the blood vessels.
(05 Mar 2000)
ascending degeneration Retrograde degeneration of an injured nerve fibre; i.e., toward the nerve cell of the fibre, degeneration cephalad to a spinal cord lesion.
(05 Mar 2000)
atheromatous degeneration Focal accumulation of lipid material (atheroma) in the intima and subintimal portion of arteries, eventually resulting in fibrous thickening or calcification.
(05 Mar 2000)
axonal degeneration A type of peripheral nerve fibre response to insult, wherein axon death and subsequent breakdown occurs, with secondary breakdown of the myelin sheath associated; caused by focal injury to peripheral nerve fibres; often referred to as wallerian degeneration.
Synonym: axon degeneration.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á